US Hemodynamic Monitoring System Market to 2027 - Country Analysis and Forecasts by Type (Noninvasive Hemodynamic Monitoring System, Minimally Invasive Hemodynamic Monitoring System, Invasive Hemodynamic Monitoring System); Product (Monitors, Disposables); End User (Hospitals, Cath Labs, Home Care, Ambulatory Care Centers)

Abstract
The US hemodynamic monitoring system market is anticipated to reach US$ 486.39 million by 2027 from US$ 292.28 million in 2019; it is projected to grow at a CAGR of 6.7% from 2020 to 2027.

The growth of the US hemodynamic monitoring system market is mainly ascribed to the factors such as increasing product developments and approvals, rising cardiovascular disease prevalence, and growing geriatric population. However, the risks associated with invasive hemodynamic monitoring systems are likely to hinder the growth of the market in the coming years. Despite this restraint, trend such as increasing preference for noninvasive devices is likely have a major impact on the market growth during the forecast period.

Hemodynamic monitoring involves the measurement of cardiac functions by determining blood circulation pattern inside veins, heart, and arteries. The monitoring of these parameters allows physicians to estimate the amount of oxygen that is being distributed in tissues and organs of the human body. Hemodynamic monitoring systems are used for measuring blood pressure inside veins, arteries, and heart. These systems are also used to measure blood flow and oxygen levels.

The prevalence of cardiovascular diseases in the US, which is a leading cause of death across the country, is much higher; >50% the population is suffering from some or other cardiovascular disease. According to the Centers for Disease Control and Prevention, every year, more than 0.6 million people die due to cardiovascular disease; this nearly accounts for one in every four deaths. Hypertension, obesity, and diabetes are the major conditions leading to the onset of cardiovascular disease among people. According to data published by American Heart Association on January 31, 2019, over 130 million or 45.1% of people are likely to have some form of cardiovascular disease by 2035 in the US.

The prevalence of cardiovascular diseases has propelled developments in the US healthcare sector, and various healthcare facilities across the country have increased the number of services. Hemodynamic monitoring systems assist them in offering better and advanced services to the majority of the cardiovascular disease patients admitted to intensive care units. These systems have become important tool for diagnosis as they assist physicians treating patients with tissue hypoperfusion conditions.

The invasive hemodynamic monitoring systems accounted for a larger share of the US hemodynamic monitoring system market, by type, in 2019. However, the noninvasive hemodynamic monitoring systems segment is expected to register a higher CAGR in the market during the forecast period.

Further, the disposables segment held largest share of the US hemodynamic monitoring system market, based on product, whereas the monitors segment is expected to witness the highest CAGR in the market during the forecast period.

Moreover, in 2019, the hospitals segment held the largest share of the US hemodynamic monitoring system market, by end user; it is further projected to dominate the market during the forecast period owing to the constant need for hospitals as primary healthcare centers.

A few of the significant primary and secondary sources studied for preparing this report on the US hemodynamic monitoring system market are National Cardiovascular Data Registry, and Food and Drug Administration (FDA).

Content
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 US Hemodynamic Monitoring System Market – By Type
1.3.2 US Hemodynamic Monitoring System Market – By Product
1.3.3 US Hemodynamic Monitoring System Market – By End User
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. US Hemodynamic Monitoring System Market Landscape
4.1 Market Overview
4.2 PEST Analysis
4.2.1 US: PEST Analysis
4.3 Expert Opinion
5. US Hemodynamic Monitoring System Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing product developments and approvals
5.1.2 Rising cardiovascular disease prevalence
5.1.3 Growing geriatric population
5.2 Market Restraints
5.2.1 Risks associated with invasive hemodynamic monitoring systems
5.3 Market Opportunities
5.3.1 Changing medical and financial conditions in developing nations
5.4 Future Trends
5.4.1 Increasing trend for noninvasive devices
5.5 Impact Analysis of Drivers and Restraints
6. Hemodynamic Monitoring System – US Market Analysis
6.1 US Hemodynamic Monitoring System Market Overview
6.2 Market Positioning of Key Players
7. US Hemodynamic Monitoring System Market Analysis – By Type
7.1 Overview
7.2 US Hemodynamic Monitoring System Market, By Type (2019 and 2027)
7.3 Noninvasive Hemodynamic Monitoring System
7.3.1 Overview
7.3.2 Noninvasive Hemodynamic Monitoring System: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
7.3.3 NICaS
7.3.3.1 Overview
7.3.3.2 NICaS: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
7.3.4 Others
7.3.4.1 Overview
7.3.4.2 Others: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
7.4 Minimally Invasive Hemodynamic Monitoring System
7.4.1 Overview
7.4.2 Minimally Invasive Hemodynamic Monitoring System: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
7.5 Invasive Hemodynamic Monitoring System
7.5.1 Overview
7.5.2 Invasive Hemodynamic Monitoring System: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
8. US Hemodynamic Monitoring System Market Analysis – By Product
8.1 Overview
8.2 US Hemodynamic Monitoring System Market, By Product (2019 and 2027)
8.3 Monitors
8.3.1 Overview
8.3.2 Monitors: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
8.4 Disposables
8.4.1 Overview
8.4.2 Disposables: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
9. US Hemodynamic Monitoring System Market Analysis – By End User
9.1 Overview
9.2 US Hemodynamic Monitoring System Market, By End User (2019 and 2027)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
9.4 Cath Labs
9.4.1 Overview
9.4.2 Cath Labs: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
9.5 Home Care
9.5.1 Overview
9.5.2 Home Care: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
9.6 Ambulatory Care Centers
9.6.1 Overview
9.6.2 Ambulatory Care Centers: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
10. US Hemodynamic Monitoring Systems Market –Industry Landscape
10.1 Overview
11. COMPANY PROFILES
11.1 Koninklijke Philips N.V.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Osypka Medical GmbH
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 General Electric Company
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Edwards Lifesciences Corporation
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Schwarzer Cardiotek
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 LiDCO
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Getinge Group
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 DELTEX MEDICAL
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 ICU MEDICAL INC.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Cheetah Medical (Baxter International)
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Word Index


LIST OF TABLES
Table 1. List of Abbreviation

LIST OF FIGURES
Figure 1. US Hemodynamic Monitoring System Market Segmentation
Figure 2. US Hemodynamic Monitoring System Market Overview
Figure 3. Invasive Hemodynamic Monitoring System is Expected to Show Remarkable Growth During Forecast Period
Figure 4. Monitors is Expected to Have Fastest Growth During Forecast Period
Figure 5. US: PEST Analysis
Figure 6. Expert Opinion
Figure 7. US Hemodynamic Monitoring System Market – Impact Analysis of Drivers and Restraints
Figure 8. Overview of US Hemodynamic Monitoring System Market
Figure 9. Market Positioning Of Key Players In US Hemodynamic Monitoring System Market
Figure 10. US Hemodynamic Monitoring System Market Revenue Share, by Type (2019 and 2027)
Figure 11. Noninvasive Hemodynamic Monitoring System: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 12. NICaS: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 13. Others: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 14. Minimally Invasive Hemodynamic Monitoring System: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 15. Invasive Hemodynamic Monitoring System: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 16. US Hemodynamic Monitoring System Market Revenue Share, by Product (2019 and 2027)
Figure 17. Monitors: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 18. Disposables: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 19. US Hemodynamic Monitoring System Market Revenue Share, by End User (2019 and 2027)
Figure 20. Hospitals: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 21. Cath Labs: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 22. Home Care: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)
Figure 23. Ambulatory Care Centers: US Hemodynamic Monitoring System Market – Revenue, and Forecast to 2027 (US$ Million)